Medpace Holdings Future Growth
Future criteria checks 3/6
Medpace Holdings is forecast to grow earnings and revenue by 9.6% and 9.2% per annum respectively. EPS is expected to grow by 9.2% per annum. Return on equity is forecast to be 40.1% in 3 years.
Key information
9.6%
Earnings growth rate
9.2%
EPS growth rate
Life Sciences earnings growth | 16.1% |
Revenue growth rate | 9.2% |
Future return on equity | 40.1% |
Analyst coverage | Good |
Last updated | 21 Feb 2025 |
Recent future growth updates
Medpace Holdings, Inc. Just Recorded A 5.6% EPS Beat: Here's What Analysts Are Forecasting Next
Feb 14Medpace Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Jul 25Recent updates
Medpace Holdings, Inc. Just Recorded A 5.6% EPS Beat: Here's What Analysts Are Forecasting Next
Feb 14Medpace: Impressive Revenue Growth, High ROE Values, And High Growth Potential
Feb 06Medpace Holdings, Inc.'s (NASDAQ:MEDP) Price Is Out Of Tune With Earnings
Jan 28Here's Why Medpace Holdings (NASDAQ:MEDP) Has Caught The Eye Of Investors
Dec 26Is Now The Time To Look At Buying Medpace Holdings, Inc. (NASDAQ:MEDP)?
Nov 22Medpace: Buy The Short-Term Pain For Long-Term Gains
Oct 26Why Medpace Holdings Is A 'Better Mousetrap'
Oct 16Medpace Holdings, Inc.'s (NASDAQ:MEDP) Earnings Haven't Escaped The Attention Of Investors
Sep 19Should You Be Adding Medpace Holdings (NASDAQ:MEDP) To Your Watchlist Today?
Sep 02Medpace: Continued Business Growth With Asymmetrical Payoff Opportunity
Aug 20Why Medpace Holdings' (NASDAQ:MEDP) Earnings Are Better Than They Seem
Jul 31Medpace Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Jul 25What You Can Learn From Medpace Holdings, Inc.'s (NASDAQ:MEDP) P/E
Jun 18Medpace: Clear Winner If China Blockade Succeeds
Jun 04A Look At The Fair Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)
May 22Does Medpace Holdings (NASDAQ:MEDP) Deserve A Spot On Your Watchlist?
Apr 12Medpace: Exceptional Performance, Almost Fully Priced In
Mar 11Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2027 | 2,666 | 486 | 633 | 670 | 7 |
12/31/2026 | 2,406 | 438 | 548 | 585 | 11 |
12/31/2025 | 2,163 | 390 | 418 | 453 | 9 |
12/31/2024 | 2,109 | 404 | 572 | 609 | N/A |
9/30/2024 | 2,071 | 366 | 536 | 575 | N/A |
6/30/2024 | 2,030 | 340 | 503 | 540 | N/A |
3/31/2024 | 1,963 | 312 | 473 | 506 | N/A |
12/31/2023 | 1,886 | 283 | 397 | 433 | N/A |
9/30/2023 | 1,782 | 273 | 378 | 414 | N/A |
6/30/2023 | 1,673 | 268 | 373 | 408 | N/A |
3/31/2023 | 1,563 | 257 | 385 | 422 | N/A |
12/31/2022 | 1,460 | 245 | 351 | 388 | N/A |
9/30/2022 | 1,374 | 227 | 286 | 322 | N/A |
6/30/2022 | 1,286 | 209 | 250 | 286 | N/A |
3/31/2022 | 1,213 | 199 | 221 | 252 | N/A |
12/31/2021 | 1,142 | 181 | 235 | 263 | N/A |
9/30/2021 | 1,094 | 182 | 271 | 298 | N/A |
6/30/2021 | 1,028 | 175 | 256 | 285 | N/A |
3/31/2021 | 955 | 159 | 235 | 267 | N/A |
12/31/2020 | 926 | 145 | 227 | 259 | N/A |
9/30/2020 | 896 | 124 | 181 | 210 | N/A |
6/30/2020 | 882 | 107 | 188 | 215 | N/A |
3/31/2020 | 891 | 110 | 196 | 217 | N/A |
12/31/2019 | 861 | 100 | 184 | 202 | N/A |
9/30/2019 | 823 | 93 | 169 | 184 | N/A |
6/30/2019 | 786 | 88 | 160 | 173 | N/A |
3/31/2019 | 742 | 78 | 153 | 167 | N/A |
12/31/2018 | 705 | 73 | 141 | 157 | N/A |
9/30/2018 | 612 | 61 | N/A | 146 | N/A |
6/30/2018 | 531 | 52 | N/A | 132 | N/A |
3/31/2018 | 456 | 45 | N/A | 121 | N/A |
12/31/2017 | 386 | 39 | N/A | 97 | N/A |
9/30/2017 | 382 | 28 | N/A | 98 | N/A |
6/30/2017 | 379 | 23 | N/A | 101 | N/A |
3/31/2017 | 377 | 18 | N/A | 78 | N/A |
12/31/2016 | 371 | 13 | N/A | 92 | N/A |
9/30/2016 | 361 | 5 | N/A | 91 | N/A |
6/30/2016 | 348 | 0 | N/A | 80 | N/A |
3/31/2016 | 332 | -5 | N/A | 94 | N/A |
12/31/2015 | 320 | -9 | N/A | 86 | N/A |
12/31/2014 | 290 | -16 | N/A | 75 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MEDP's forecast earnings growth (9.6% per year) is above the savings rate (2.8%).
Earnings vs Market: MEDP's earnings (9.6% per year) are forecast to grow slower than the US market (13.9% per year).
High Growth Earnings: MEDP's earnings are forecast to grow, but not significantly.
Revenue vs Market: MEDP's revenue (9.2% per year) is forecast to grow faster than the US market (8.4% per year).
High Growth Revenue: MEDP's revenue (9.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MEDP's Return on Equity is forecast to be very high in 3 years time (40.1%).
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/03/10 19:27 |
End of Day Share Price | 2025/03/07 00:00 |
Earnings | 2024/12/31 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Medpace Holdings, Inc. is covered by 18 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Eric Coldwell | Baird |
Ishan Majumdar | Baptista Research |
Erin Wilson Wright | Credit Suisse |